Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease

Area of Science:

• Nephrology
• Cardiology
• Hematology

Background:

• Chronic kidney disease (CKD) is an established independent risk factor for cardiovascular disease (CVD).
• Anemia is a frequent complication of CKD, especially in end-stage renal disease.
• Anemia independently worsens outcomes in various CVD conditions, including heart failure and coronary artery disease.

Purpose of the Study:

• To review the evidence linking CKD, anemia, and CVD.
• To highlight the importance of understanding the pathophysiologic connections between these conditions.

Main Methods:

• Literature review of existing studies on CKD, anemia, and CVD.
• Analysis of the association between hemoglobin levels and mortality in CKD patients.

Main Results:

• Anemia acts as an independent mortality multiplier when hemoglobin is below 12 g/dL.
• Both CKD and anemia significantly contribute to cardiovascular morbidity and mortality.
• Erythropoietin therapy is under investigation for mitigating cardiovascular risk in CKD and anemia.

Conclusions:

• CKD and anemia are significant independent contributors to cardiovascular mortality.
• Understanding the pathophysiologic links is crucial for effective management.
• Investigational therapies like erythropoietin may improve outcomes for patients with CKD and anemia.